Martin Wilson

This profile gathers the share dealings of Martin Wilson in Rocket Pharmaceuticals, Inc., where the filings describe the role as board member. In total, 22 filings cover trades dated from 14 February 2024 to 11 September 2026.

Every open-market trade on record is a sale: 16 sales worth €603k. Outside the open market, there are 4 share grants and 2 option exercises. 2026 to date brings no purchases and 6 sales.

Most recently, on 15 September 2026, the filings show an open-market sale worth €221k in Rocket Pharmaceuticals, Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.